Compounds > ciprofloxacin

ciprofloxacin and brl 28500

ciprofloxacin has been researched along with brl 28500 in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's3 (33.33)18.2507
2000's2 (22.22)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baetz, R; Borner, K; Lebahn, K; Lode, H; Olschewski, P; Reinke, M; Sievers, H; Wagner, J; Wiley, E; Wintermantel, M1
Gruninger, R; Guay, DR; Gustilo, RB; Peterson, PK; Tsukayama, DT; Wicklund, B1
Low, DE; Matsumura, SO; McGeer, A; Poulos, CD; Willey, BM1
Blondeau, JM; Suter, M; Vaughan, D; Yaschuk, Y1
Armand, JP; Carmois, T; Casassus-Builhé, D; Chauveau, E; Le Bougeant, P; Oddes, B; Terrier, F1
Boni, V; Braccini, G; Braggion, C; Campana, S; Festini, F; Galici, V; Neri, AS; Taccetti, G; Trevisan, F; Zavataro, L1
Al-Hamad, A; Burnie, J; Upton, M1
Chmura, A; Ciszek, M; Dobrzaniecka, K; Durlik, M; Kwiatkowski, A; Mlynarczyk, A; Mlynarczyk, G; Paczek, L; Sawicka-Grzelak, A; Szymanek-Majchrzak, K; Usarek, P1
Grimwood, K; Harun, SN; Hennig, S; Holford, NHG; Wainwright, CE1

Trials

1 trial(s) available for ciprofloxacin and brl 28500

ArticleYear
Prospective randomized clinical trials of new quinolones versus beta-lactam antibiotics in lower respiratory tract infections.
    Scandinavian journal of infectious diseases. Supplementum, 1990, Volume: 68

    Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Clavulanic Acids; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Ofloxacin; Pneumonia; Prospective Studies; Remission Induction; Respiratory Tract Infections; Sepsis; Ticarcillin

1990

Other Studies

8 other study(ies) available for ciprofloxacin and brl 28500

ArticleYear
The effect of anaerobiosis on antistaphylococcal antibiotics.
    Orthopedics, 1988, Volume: 11, Issue:9

    Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anaerobiosis; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Clavulanic Acids; Clindamycin; Coagulase; Drug Therapy, Combination; Glycopeptides; Microbial Sensitivity Tests; Staphylococcus; Teicoplanin; Ticarcillin; Tobramycin; Vancomycin

1988
In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilia.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:10

    Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Clavulanic Acids; Microbial Sensitivity Tests; Ticarcillin; Trimethoprim, Sulfamethoxazole Drug Combination; Xanthomonas

1995
In-vitro susceptibility of 1982 respiratory tract pathogens and 1921 urinary tract pathogens against 19 antimicrobial agents: a Canadian multicentre study. Canadian Antimicrobial Study Group.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 43 Suppl A

    Topics: Acinetobacter; Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Ciprofloxacin; Clavulanic Acids; Enterobacteriaceae; Enterobacteriaceae Infections; Enterococcus; Haemophilus; Humans; Imipenem; Inhibitory Concentration 50; Microbial Sensitivity Tests; Moraxella; Pseudomonas; Respiratory Tract Infections; Staphylococcus; Streptococcus; Ticarcillin; Urinary Tract Infections

1999
[Hepatic inflammatory pseudotumor regressing with antibiotic therapy].
    Presse medicale (Paris, France : 1983), 2002, May-25, Volume: 31, Issue:18

    Topics: Aged; Biopsy; Ciprofloxacin; Clavulanic Acids; Drug Therapy, Combination; Female; Granuloma, Plasma Cell; Humans; Liver; Liver Diseases; Magnetic Resonance Imaging; Ticarcillin; Treatment Outcome

2002
The costs of treatment of early and chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Ceftazidime; Child, Preschool; Chronic Disease; Ciprofloxacin; Clavulanic Acids; Colistin; Cost of Illness; Cystic Fibrosis; Humans; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins; Ticarcillin; Tobramycin

2009
Enhancement of antibiotic susceptibility of Stenotrophomonas maltophilia using a polyclonal antibody developed against an ABC multidrug efflux pump.
    Canadian journal of microbiology, 2011, Volume: 57, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Antibodies, Bacterial; ATP-Binding Cassette Transporters; Ciprofloxacin; Clavulanic Acids; Drug Synergism; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Rabbits; Stenotrophomonas maltophilia; Ticarcillin; Trimethoprim, Sulfamethoxazole Drug Combination

2011
Drug Susceptibility Assessment in Stenotrophomonas Maltophilia Strains Isolated From the Blood of Organ Transplantation Recipients in a Warsaw Teaching Hospital During 2011 to 2014.
    Transplantation proceedings, 2016, Volume: 48, Issue:5

    Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Clavulanic Acids; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; Levofloxacin; Microbial Sensitivity Tests; Organ Transplantation; Stenotrophomonas maltophilia; Ticarcillin; Transplant Recipients; Trimethoprim, Sulfamethoxazole Drug Combination

2016
    Thorax, 2019, Volume: 74, Issue:8

    Topics: Anti-Bacterial Agents; Bronchoalveolar Lavage; Ceftazidime; Child, Preschool; Ciprofloxacin; Clavulanic Acids; Cross-Sectional Studies; Cystic Fibrosis; Female; Humans; Infant; Longitudinal Studies; Male; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Pulmonary Aspergillosis; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Ticarcillin; Tobramycin

2019